Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

PharmaNet/i3 Named Distinguished Partner by US-China Anti-Cancer Group

publication date: Jun 27, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
PharmaNet/i3, the clinical-stage CRO division of inVentiv Health, received the Distinguished Partner Award from the US Chinese Anti-Cancer Association (USCACA) for its support of oncology clinical trials and cancer research in China. PharmNet/i3 has conducted 250 clinical trials in Asia and the Pacific Rim. The company has offices in Japan, Korea and China. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...